← Leaderboards
Longchuan Bai
University Of Michigan At Ann Arbor
$804,582
Attributed
$1,609,163
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $322.7K · FY2014–18$500K$375K$250K$125K$0
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$1,609,163 · 1
By mechanism
R01$1,609,163 · 1
Top collaborators
- Shaomeng Wang5 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Sami Nimer Malek$8,691,121
- Martin Philbert$6,712,530
- Max S. Wicha$49,028,071
- Robert M Strieter$9,675,893
- Judith S Leopold$7,991,997
Others in their field
Top investigators on “Addiction”
- Wafaa M. El-Sadr · Columbia University Health Sciences$122,006,808
- Sten H Vermund · University Of Alabama At Birmingham$115,253,143
- Jeffrey H Samet · Boston University Medical Campus$108,787,548
- Myron S Cohen · Family Health International$101,800,876
- Sharon L. Walsh · University Of Kentucky$92,602,816
- Jeffrey S Flier · Beth Israel Deaconess Medical Center$89,041,364
Research focus
AddictionFda ApprovedApoptoticBaseApoptosisBcl2 GeneBcl2l1 GeneBlood PlateletsBurden Of IllnessCancer Cell LineBcl1 OncogeneCell LineCellsCessation Of LifeChronic Lymphocytic LeukemiaClinical EfficacyClinical TrialsDocetaxelDoseEffectivenessEffective TherapyExhibitsCancer PatientImmune
Grant awards (5)
Development of a dual small-molecule BCl-XL/BCL-2 inhibitor for non-small cell lu$321,625
R01 · FY2018 · CA
Development of a dual small-molecule BCl-XL/BCL-2 inhibitor for non-small cell lu$321,625
R01 · FY2017 · CA
Development of a dual small-molecule BCl-XL/BCL-2 inhibitor for non-small cell lu$321,625
R01 · FY2016 · CA
Development of a dual small-molecule BCl-XL/BCL-2 inhibitor for non-small cell lu$321,625
R01 · FY2015 · CA
Development of a dual small-molecule BCl-XL/BCL-2 inhibitor for non-small cell lu$322,663
R01 · FY2014 · CA